Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patientsONO, Atsushi; SUZUKI, Fumitaka; IKEDA, Kenji et al.Journal of hepatology. 2012, Vol 57, Num 3, pp 508-514, issn 0168-8278, 7 p.Article

IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis CCHAYAMA, Kazuaki; NELSON HAYES, C; KOBAYASHI, Mariko et al.The Journal of infectious diseases. 2011, Vol 204, Num 1, pp 84-93, issn 0022-1899, 10 p.Article

Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevirSUZUKI, Fumitaka; SUZUKI, Yoshiyuki; SAITO, Satoshi et al.Journal of clinical virology. 2010, Vol 47, Num 1, pp 76-78, issn 1386-6532, 3 p.Article

Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in japanese patients infected with hepatitis C virus genotype 1bAKUTA, Norio; SUZUKI, Fumitaka; IKEDA, Kenji et al.Journal of medical virology. 2007, Vol 79, Num 11, pp 1686-1695, issn 0146-6615, 10 p.Article

Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis CARASE, Yasuji; IKEDA, Kenji; KOBAYASHI, Mariko et al.Journal of medical virology. 2007, Vol 79, Num 8, pp 1095-1102, issn 0146-6615, 8 p.Article

Long-term outcome of HBV carriers with negative hbe antigen and normal aminotransferase : Infectious diseaseIKEDA, Kenji; ARASE, Yasuji; KUMADA, Hiromitsu et al.The American journal of medicine. 2006, Vol 119, Num 11, pp 977-985, issn 0002-9343, 9 p.Article

Long-term follow-up of interferon monotherapy in 454 consecutive naive patients infected with hepatitis C virus : Multi-course interferon therapy may reduce the risk of hepatocellular carcinoma and increase survivalAKUTA, Norio; SUZUKI, Fumitaka; KOBAYASHI, Mariko et al.Scandinavian journal of gastroenterology. 2005, Vol 40, Num 6, pp 688-696, issn 0036-5521, 9 p.Article

Emergence of Telaprevir-Resistant Variants Detected by Ultra-Deep Sequencing After Triple Therapy in Patients Infected With HCV Genotype 1AKUTA, Norio; SUZUKI, Fumitaka; SAITOH, Satoshi et al.Journal of medical virology. 2013, Vol 85, Num 6, pp 1028-1036, issn 0146-6615, 9 p.Article

Association of IL28B Genotype and Viral Response of Hepatitis C Virus Genotype 2 to Interferon Plus Ribavirin Combination TherapyAKUTA, Norio; SUZUKI, Fumitaka; ARASE, Yasuji et al.Journal of medical virology. 2012, Vol 84, Num 10, pp 1593-1599, issn 0146-6615, 7 p.Article

Previous Chemoembolization Response after Transcatheter Arterial Chemoembolization (TACE) Can Predict the Anti-Tumor Effect of Subsequent TACE with Miriplatin in Patients with Recurrent Hepatocellular CarcinomaIMAI, Norihiro; IKEDA, Kenji; SUZUKI, Yoshiyuki et al.Oncology. 2011, Vol 80, Num 3-4, pp 188-194, issn 0030-2414, 7 p.Article

Amino Acid Substitution in Hepatitis C Virus Core Region and Genetic Variation Near the Interleukin 28B Gene Predict Viral Response to Telaprevir with Peginterferon and RibavirinAKUTA, Norio; SUZUKI, Fumitaka; SAITOH, Satoshi et al.Hepatology (Baltimore, Md.). 2010, Vol 52, Num 2, pp 421-429, issn 0270-9139, 9 p.Article

A Matched Case-Controlled Study of 48 and 72 Weeks of Peginterferon Plus Ribavirin Combination Therapy in Patients Infected With HCV Genotype 1b in Japan : Amino Acid Substitutions in HCV Core Region as Predictor of Sustained Virological ResponseAKUTA, Norio; SUZUKI, Fumitaka; SAITOH, Satoshi et al.Journal of medical virology. 2009, Vol 81, Num 3, pp 452-458, issn 0146-6615, 7 p.Article

Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levelsKOBAYASHI, Mariko; SUZUKI, Fumitaka; IKEDA, Kenji et al.Scandinavian journal of gastroenterology. 2009, Vol 44, Num 8, pp 975-983, issn 0036-5521, 9 p.Article

Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudineKOBAYASHI, Mariko; SUZUKI, Fumitaka; IKEDA, Kenji et al.Journal of medical virology. 2007, Vol 79, Num 10, pp 1472-1477, issn 0146-6615, 6 p.Article

Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutantsSUZUKI, Fumitaka; AKUTA, Norio; KOBAYASHI, Mariko et al.Journal of medical virology. 2006, Vol 78, Num 3, pp 341-352, issn 0146-6615, 12 p.Article

Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and CKOBAYASHI, Mariko; SUZUKI, Fumitaka; SATO, Junko et al.Journal of medical virology. 2006, Vol 78, Num 10, pp 1276-1283, issn 0146-6615, 8 p.Article

Diabetes Enhances Hepatocarcinogenesis in Noncirrhotic, Interferon-treated Hepatitis C PatientsKAWAMURA, Yusuke; ARASE, Yasuji; SUZUKI, Fumitaka et al.The American journal of medicine. 2010, Vol 123, Num 10, pp 951-956, issn 0002-9343, 6 p.Article

Influence of Amino-Acid Polymorphism in the Core Protein on Progression of Liver Disease in Patients Infected With Hepatitis C Virus Genotype 1bKOBAYASHI, Mariko; AKUTA, Norio; MINETA, Rie et al.Journal of medical virology. 2010, Vol 82, Num 1, pp 41-48, issn 0146-6615, 8 p.Article

Virus Clearance Reduces Bone Fracture in Postmenopausal Women With Osteoporosis and Chronic Liver Disease Caused by Hepatitis C VirusARASE, Yasuji; SUZUKI, Fumitaka; IKEDA, Kenji et al.Journal of medical virology. 2010, Vol 82, Num 3, pp 390-395, issn 0146-6615, 6 p.Article

Losartan Reduces the Onset of Type 2 Diabetes in Hypertensive Japanese Patients With Chronic Hepatitis CARASE, Yasuji; SUZUKI, Fumitaka; SAITO, Satoshi et al.Journal of medical virology. 2009, Vol 81, Num 9, pp 1584-1590, issn 0146-6615, 7 p.Article

Sustained Virological Response Reduces Incidence of Onset of Type 2 Diabetes in Chronic Hepatitis CARASE, Yasuji; SUZUKI, Fumitaka; IKEDA, Kenji et al.Hepatology (Baltimore, Md.). 2009, Vol 49, Num 3, pp 739-744, issn 0270-9139, 6 p.Article

Efficacy of Low-Dose Intermittent Interferon-Alpha Monotherapy in Patients Infected With Hepatitis C Virus Genotype 1b Who Were Predicted or Failed to Respond to Pegylated Interferon Plus Ribavirin Combination TherapyAKUTA, Norio; SUZUKI, Fumitaka; IKEDA, Kenji et al.Journal of medical virology. 2008, Vol 80, Num 8, pp 1363-1369, issn 0146-6615, 7 p.Article

Natural history of compensated cirrhosis in the child-pugh class A compared between 490 patients with hepatitis C and 167 with B virus infectionsKOBAYASHI, Masahiro; IKEDA, Kenji; MIYAKAWA, Yuzo et al.Journal of medical virology. 2006, Vol 78, Num 4, pp 459-465, issn 0146-6615, 7 p.Article

Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B : An 8-year follow-up studyAKUTA, Norio; SUZUKI, Fumitaka; KOBAYASHI, Mariko et al.Journal of medical virology. 2005, Vol 75, Num 4, pp 491-498, issn 0146-6615, 8 p.Article

Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis BTSUBOTA, Akihito; ARASE, Yasuji; IKEDA, Kenji et al.Journal of gastroenterology and hepatology. 2005, Vol 20, Num 3, pp 426-432, issn 0815-9319, 7 p.Article